会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • COMPOSITION FOR PREVENTION, INHIBITION AND TREATMENT OF OBESITY AND RELATED DISEASES
    • 用于预防,抑制和治疗肥胖及相关疾病的组合物
    • WO2005036990A1
    • 2005-04-28
    • PCT/EP2004/010907
    • 2004-09-30
    • TIENSE SUIKERRAFFINADERIJ N.V.DELZENNE, Nathalie, MariaCANI, Patrice, DanielFRIPPIAT, Anne
    • DELZENNE, Nathalie, MariaCANI, Patrice, DanielFRIPPIAT, Anne
    • A23L1/308
    • A23L33/24A23L33/22A23L33/30
    • The use is provided of a combination of a fermentable dietary fibre and a food product for the manufacture of a composition for oral administration or tube feeding for the prevention, the inhibition of the development, and the treatment of obesity and obesity-related diseases in humans and mammals. The composition inhibits the synthesis and/or release and the effects of the appetite-stimulating hormone ghrelin, and provokes a suppression of plasma ghrelin levels that in the post-absorptive period 8 hours after intake is preferably at least 30 % lower than the plasma ghrelin concentration of controls having taken only said food product. Also a method is provided for the prevention, the inhibition of the development, and the treatment of overweight, obesity and obesity-related diseases in humans and mammals. A method is provided too for suppressing plasma ghrelin levels, for inhibiting the synthesis and/or release and the effects of the appetite-stimulating hormone ghrelin, in humans and mammals. The methods involve oral intake or administration through tube feeding of a composition comprising said combination of fermentable dietary fibre and food product.
    • 提供了可发酵膳食纤维和食品的组合的用途,用于制造用于口服或管饲的组合物,用于预防,抑制发育,以及治疗人体中的肥胖和肥胖相关疾病 和哺乳动物。 该组合物抑制食欲刺激激素生长素释放肽的合成和/或释放和作用,并且引起血浆生长素释放肽水平的抑制,其在摄入后8小时的吸收后期间优选比血浆生长素释放肽低至少30% 对照品的浓度仅服用所述食品。 还提供了用于预防,抑制发育以及治疗人和哺乳动物中的超重,肥胖和肥胖相关疾病的方法。 还提供了一种抑制血浆生长素释放肽水平的方法,用于抑制人和哺乳动物中促进激素的生长素释放肽的合成和/或释放及其作用。 所述方法涉及口服摄入或通过管饲喂包含所述可发酵膳食纤维和食品的组合的组合物。
    • 5. 发明申请
    • SYNERGISTIC COMBINATIONS OF DIETARY FIBER AND N-SAIDS FOR THE TREATMENT OF CANCER
    • 用于治疗癌症的膳食纤维和N-糖苷的协同组合
    • WO2004028527A1
    • 2004-04-08
    • PCT/EP2003/010544
    • 2003-09-23
    • TIENSE SUIKERRAFFINADERIJ N.V.VAN LOO, JanFRIPPIAT, AnneHERMANS, Johny
    • VAN LOO, JanFRIPPIAT, AnneHERMANS, Johny
    • A61K31/19
    • A61K31/19A61K31/715
    • Pharmaceutical compositions are disclosed that present synergistic anti-cancer effects in humans and vertebrate animals, comprising a combination of a fermentable dietary fiber (FDF) which is a fructan and a non-steroidal anti-inflammatory drug (NSAID) with cyclo-oxygenase2 (COX2) inhibiting activity, the FDF being present in the FDF/NSAID combination in a weight ratio FDF: NSAID of minimum 1:1. Typical compositions comprise a FDF/NSAID combination wherein the FDF component is chicory inulin, oligofructose or a mixture thereof, and the NSAID component is sulindac, piroxicam or aspirin. The synergistic ant-cancer effects of the compositions are demonstrated in aberrant crypt foci studies in rats. The pharmaceutical compositions are useful in the prevention and inhibition of carcinogenesis or recurrence of cancer and for the treatment of cancer in humans and vertebrate animals. The invention also relates to a method for prevention or inhibition of carcinogenesis and recurrence of cancer and for the treatment of cancer in humans and vertebrate animals involving administration of a therapeutically effective dose of said pharmaceutical compositions to a human or vertebrate animal.
    • 公开了药物组合物,其在人和脊椎动物中表现出协同的抗癌作用,其包括作为果聚糖的可发酵膳食纤维(FDF)和非甾体抗炎药(NSAID)与环氧合酶2(COX2)的组合 )抑制活性,FDF存在于FDF / NSAID组合中,重量比FDF:NSAID最小为1:1。 典型的组合物包含FDF / NSAID组合,其中FDF组分是菊苣菊糖,低聚果糖或其混合物,NSAID组分是舒林酸,吡罗昔康或阿司匹林。 在大鼠的异常隐窝灶研究中证明了组合物的协同抗癌作用。 药物组合物可用于预防和抑制癌症的癌发生或复发以及用于治疗人类和脊椎动物的癌症。 本发明还涉及用于预防或抑制癌症的癌发生和复发以及用于治疗人类和脊椎动物中的癌症的方法,其涉及向人或脊椎动物施用治疗有效剂量的所述药物组合物。